Oil and its derivatives. The foundations of chemotherapy of leprosy can be said to have been laid early in this century with the isolation of hydnocarpic and chaulmoogric acids, believed to be the active principles of the oil, and the preparation of sodium salts of these acids. The introduction of sulphone drugs in the treatment of leprosy about 12 years ago, has initiated a new era in the chemotherapy of leprosy.
Since then great advances have baen made in this field.
These advances in chemotherapy of leprosy have been made possible by following the progress of chemotherapy in tuberculosis, and putting to trial in leprosy remedies reported to have been successfully used in the treatment of that disease.
This approach which has been necessitated by the fact that research in leprosy is greatly handicaped by the non-cultivation of the leprosy bacillus, and the absence of a susceptible laboratory animal, has been amply justified by the results obtained.
Following this lead, drugs like the Sulphones, Streptomycin, Aureomycin, P.A. S., Thiosemicar- bazone, and Isonicotynyl Hydrazide, have been put to trial in leprosy. Of these, sulphones have given the most 'encouraging results and have been most widely used. Thiosemicarbazones, though yet not so widely used, appear to be of definite value. The other drugs do not appear to be of value as basic remedies for the treatment of leprosy, though they may be useful for treatment of certain acute conditions or as adjuvant methods of treatment.
It is proposed in this article to deal with the sulphones in some detail as these remedies are [Jan., 1953 now (1937) , Fourneau et al. (1937) and Bauer and Rosenthal (1938) found that this substance had a great a.nti-bacterial power against streptococcal infection in mice, and to some extent in rabbits and monkeys. Buttle et al. found that in man a single dose of 300 mg. produced definite antibacterial effect in the blood. The drug was later tried in human beings with acute infections, in doses of 1 to 2 mg. a day, but the treatment was soon abandoned because of the rapid production of methsemoglobinsemia and other toxic effects. In veterinary medicine however it established itself as a powerful anti-bacterial agent. (1940) and Feldman et al (1940) reported on its anti-tuberculous activity in experimental tuberculosis in rabbits and guinea-* pigs. This was followed by extensive trials of the parent compound and its derivatives in experimental tuberculosis in guineapigs, and of the derivatives in human tuberculosis. The The literature on the subject has been fast increasing, and several excellent reviews have appeared during recent years. No attempt will be made to present a bibliography of the literature, and references will be quoted only when dealing with certain aspects, such as the metabolism of sulphones, etc.
Chemical Composition
The Parent Substance Diamino-diphenyl-sulphone, the parent compound of the group, is allied to the well known compound sulphanilamide, better described as p-aminobenzen sulphonamide. Sulphanilamide contains one benzene ring to one end of which in the para position is attached an NH2 radical, and to the other end an S02 combined with NH2, the structural formula being NH2 S02NH?. Diamino-diphenyl-sulphone consists of two benzene rings joined by an S02 radical, and with an NH2 radical attached to each of the benzene rings in the para position; the structural formula being NIL SO Francis and Spink (1950) (1951) There is another possible explanation of the activity of the injected disubstituted sulphones, and that is the possibility of partial hydrolysis with the production of active monosubstituted derivatives in the body after injection of the disubstituted sulphones. Lowe has referred to this possibility, but he considers that even if it was true injection of disubstituted sulphone was still illogical. He thinks it better to give a known amount of the sulphone known to be active, than to use a substance known to be inactive, in the expectation that it will produce an unknown and possibly varying amount of active substance.
Metabolism of Monosubstituted Sulphones
There is some evidence to the effect that monosubstituted sulphones are active by themselves, and that after injection they break down to DDS co only a small extent. Rist and Cottet (1949) expressed the opinion that monosubstituted sulphones, having a free amino, seemed to act without previous hydrolysis. Boyer et al (1949) stated that in vitro the monosubstituted sulphones seem to act by virtue of their entire molecule, but that there was a possibility that they might undergo a certain degree of hydrolysis in the body specially when given by mouth. Floch et al (1951a) estimated the amounts of sulphones before and after hydrolysis in blood and urine of 2 patients after injection of 1 gm. Succinyl-DDS (1500 F) and came to the conclusion that only a very small fraction (at the most 10%) of the injected Succinyl-DDS is converted to DDS or some DDS derivatives.
Regarding the mode of action of the monosubstituted sulphones after injection these authors in another publication [Jan., 1953 state that the activity is due at the onset to the whole molecule, later to the DDS liberated by partial hydrolysis, and finally to a sulphonated product formed in the body from the monosubstituted sulphones. When given orally, however, a large amount of the drug undergoes hydrolysis and only about 40% is found as such in blood and urine.
In case of Hydroxyethyl-DDS Smith et al (1949) stated that the properties of a metabolite isolated from the urine of man receiving the hvdroxyethyl indicate that this is not degraded to DDS. Floch and Lacuiller (1951) Sulphone concentration determined before and after hydrolysis in the blood and urine of a small number of patients receiving 1 gm. of hydroxyethyl by mouth showed that in blood it occurred as such, and that in the urine it was excreted either as such or in the form of a metabolite.
In case of Promacetin?a nuclear monosubstituted derivative?Ross & Gemar (1951) found that " When the bloods and urines of 24 patients receiving promacetin were analysed by direct diazotization and by acid hydrolysis the values for free and total sulphone were identical, which indicates that this drug was unaltered in the body of the patients studied." However, using the ethyl acetate extraction method Dharmendra (1951) (1951) found it effective and better tolerated than any other sulphone drug. Herrera (1951) (1951) (1951) has reviewed these publications and expressed the opinion that "all the reports available up to the time pointed to the conclusion that conteben was capable of causing reduction of leprous infection". Later Schneider et al (1950) , Ryrie (1950) (1951) , Barnes (1951) , Floch & Horth (1951) , Schujman (1952) , Montestruc & Blache (1952) , Lowe (1952a) and Dharmendra and Chatterjee (1952) have reported results in larger series of leprosy cases, especially the last two publications.
Mode of Administration and Dosage TB-1 is given by mouth twice a day. Because of its rapid excretion from the body it cannot be given less frequently, say twice a week as in the case of sulphones. It is usual to give treatment for 6 days a week with a break for one day. This practice is followed in view of the very long duration of treatment, and is in consonance with the practice followed in the case of oral administration of sulphone drugs. There is no evidence to show that bacteriological clearance, which is very slow with sulphones is any quicker on this drug. Dharmendra and Chatterjee (1952) reported that in addition to the usual beneficial effects resulting in subsidence of thickening and redness of the lesions, the clinical response to thiosemicarbazone included complete or partial restoration of sensation in the ansesthetic patch.es, regenerative nail changes, and growth of new hair in the affected parts. These observations have now been confirmed by Lowe (1953 This intjlerance may be seen after the first few doses, or after the patient has been taking the drug for a few weeks. One such case has been reported by Lowe (1953) .
The most serious toxic manifestation is the occurrence of agranulocytosis as reported by Lowe (1952) . Out It may therefore be concluded that in general the toxicity of thiosemicarbazone seems to be less than that of sulphones, specially in relation to its effect on the hemopoietic system. However, serious toxic effects may-be seen more frequently than with sulphones.
Comparison with Sy^lphones
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